Incyte stock hit 11% despite paediatric dermatology trials hitting target
The US company’s two simultaneous trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.

The US company’s two simultaneous trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.
At MWC Barcelona 2025, Li Peng, Huawei's Corporate Senior Vice President and President of ICT Sales & Service, delivered a keynote on how carriers can make the most of AI...
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The AI advantage in discovering new medicines
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic